# Orgenesis Inc. (ORGS)

Source: https://www.quantisnow.com/company/ORGS
Generated: 2026-11-09T14:54:32.469Z

- Ticker: ORGS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: orgenesis.com

## About

Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. sThe company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. The company was incorporated in 2008 and is based in Germantown, Maryland.

## Latest ORGS news and filings

- 2026-04-15 22:55 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-orgenesis-inc-6501966)
- 2026-03-26 17:19 UTC [SEC Form 10-K] [SEC Form 10-K filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-orgenesis-inc-6470552)
- 2026-03-13 19:48 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-leadership-update-6446811)
- 2026-01-26 11:15 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-entry-into-a-material-6359943)
- 2025-09-16 21:29 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-entry-into-a-material-6202882)
- 2025-08-25 20:30 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-leadership-update-financial-statements-6177897)
- 2025-08-19 20:30 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-leadership-update-financial-statements-6171932)
- 2025-08-01 20:30 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-other-events-financial-statements-6143150)
- 2025-06-06 20:30 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-notice-of-delisting-or-6076597)
- 2025-05-16 20:30 UTC [SEC Form NT 10-Q filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-orgenesis-inc-6045604)
- 2025-05-08 21:21 UTC [SEC Form 25-NSE filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-orgenesis-inc-6028562)
- 2025-04-22 20:30 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-other-events-5996634)
- 2025-04-01 20:05 UTC [SEC Form NT 10-K filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-orgenesis-inc-5969593)
- 2025-03-18 20:06 UTC [SEC Form 3] [New insider Malik Ariel claimed ownership of 1,200,000 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-malik-ariel-claimed-ownership-of-1200000-shares-sec-5949593)
- 2025-03-14 20:05 UTC [SEC Form SCHEDULE 13G filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-orgenesis-inc-5944975)
- 2025-03-06 21:05 UTC [Market Insight] [Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies](https://www.quantisnow.com/insight/orgenesis-inc-announces-acquisition-of-certain-neurocords-llc-assets-strengthening-5930929)
- 2025-03-06 21:05 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-entry-into-a-material-5930882)
- 2025-01-28 13:00 UTC [Market Insight] [Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings](https://www.quantisnow.com/insight/orgenesis-secures-up-to-5-million-equity-investment-from-williamsburg-5859153)
- 2025-01-28 13:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-orgenesis-inc-5859145)
- 2024-12-27 21:30 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-leadership-update-5826029)
- 2024-12-16 19:42 UTC [SEC Form 4] [SEC Form 4 filed by Director Vider Itzhak](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-vider-itzhak-5814627)
- 2024-12-16 19:42 UTC [SEC Form 4] [SEC Form 4 filed by Director Adler Yaron](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-adler-yaron-5814626)
- 2024-12-16 19:42 UTC [SEC Form 4] [SEC Form 4 filed by Director Pelavin Adam](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-pelavin-adam-5814625)
- 2024-12-16 19:42 UTC [SEC Form 4] [SEC Form 4 filed by Director Nagaraj Santhosh](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-nagaraj-santhosh-5814624)
- 2024-12-16 19:42 UTC [SEC Form 4] [SEC Form 4 filed by Director Nanda Ashish](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-nanda-ashish-5814622)
- 2024-12-16 19:42 UTC [SEC Form 4] [SEC Form 4 filed by Director Bhalaji Jagannathan](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bhalaji-jagannathan-5814621)
- 2024-12-04 23:51 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Orgenesis Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-orgenesis-inc-5800942)
- 2024-12-04 23:50 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Orgenesis Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-orgenesis-inc-5800940)
- 2024-12-04 23:48 UTC [Insider Buy] [Large owner Safier Jacob bought $16,883 worth of shares (30,000 units at $0.56) and sold $16,259 worth of shares (30,000 units at $0.54) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-safier-jacob-bought-16883-worth-of-shares-30000-5800939)
- 2024-11-13 13:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Orgenesis Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-orgenesis-inc-5770083)
- 2024-11-13 13:00 UTC [Orgenesis Provides Third Quarter 2024 Business Update](https://www.quantisnow.com/insight/orgenesis-provides-third-quarter-2024-business-update-5770010)
- 2024-11-12 23:28 UTC [SEC Form 3] [SEC Form 3 filed by new insider Nagaraj Santhosh](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-nagaraj-santhosh-5769383)
- 2024-11-12 23:27 UTC [SEC Form 3] [SEC Form 3 filed by new insider Bhalaji Jagannathan](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-bhalaji-jagannathan-5769381)
- 2024-11-12 23:26 UTC [SEC Form 3] [SEC Form 3 filed by new insider Pelavin Adam](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-pelavin-adam-5769378)
- 2024-11-05 21:05 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-entry-into-a-material-5753200)
- 2024-11-01 20:05 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-leadership-update-financial-statements-5748220)
- 2024-10-23 21:00 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-leadership-update-5735515)
- 2024-10-21 12:00 UTC [Orgenesis Commences Trading on OTCQX® Best Market](https://www.quantisnow.com/insight/orgenesis-commences-trading-on-otcqx-best-market-5731160)
- 2024-10-17 21:09 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-notice-of-delisting-or-5729515)
- 2024-09-23 11:00 UTC [SEC Form 8-K] [Orgenesis Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orgenesis-inc-filed-sec-form-8-k-material-modification-to-rights-5701521)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ORGS
- Earnings history: https://www.quantisnow.com/earnings/ORGS
- Dividend history: https://www.quantisnow.com/dividends/ORGS
- Insider transactions: https://www.quantisnow.com/insiders/ORGS
- Options chain: https://www.quantisnow.com/options/ORGS
- SEC 8-K filings only: https://www.quantisnow.com/company/ORGS/8-k
- RSS and alerts for ORGS: https://www.quantisnow.com/docs/rss-feeds.md